Sat.Mar 30, 2024

article thumbnail

J&J's Nipocalimab for FNAIT Gets on Fast Track for Approval

PharmaTech

FDA granted fast track designation to nipocalimab, which J&J is developing for helping alloimmunized pregnant adults treat FNAIT, a rare disease that poses risk to the fetus or newborn.

FDA 52
article thumbnail

Experts Establish First Performance Measures of Lifestyle Medicine Treatments

Pharmacy Times

Investigators identify 32 performance measures in the final set grouped into 10 categories of disease or health condition.

article thumbnail

Amneal Pharmaceuticals Recalls Vancomycin Hydrochloride for Oral Solution USP, 250 mg/5 mL

PharmaTech

The company is voluntarily recalling the product for potential super potent bottles due to overfilling.